In patients age 19-64 with a high risk condition (see CDC site below), ACIP has long recommended they receive PCV 23, followed by a 2nd dose 5 years later. PCV 23 is also recommended as a one-time dose for all patients age 65 and over. Now the CDC is recommending, for patients age 19-64 with a high risk conditions, a dose of PCV 13, followed by PCV 23 at least 8 weeks later. For those high risk and in this age group who have already received PCV 23, they should also receive PCV 13 at least 1 year after their dose of PCV 23. Full recommendations are available at the CDC site (CDC site)
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.